Literature DB >> 6367167

Quantitative fluorescence analysis of cyclosporine binding to human leukocytes.

B Ryffel, K E Willard-Gallo, K Tammi, M R Loken.   

Abstract

The purpose of this investigation was to estimate the binding of cyclosporine at the single-cell level on human peripheral lymphocytes, and to test possible identity of the cyclosporine-binding site with a common receptor of T cell activation. A dansyl-coupled derivative (Dans cyclosporine) was used as a fluorescent probe. The histograms of unseparated, labeled peripheral leukocytes obtained by a fluorescence-activated cell sorter (FACS) showed that Dans cyclosporine stained all leukocytes--but two distinct populations could be separated based on the intensity of fluorescence. The more brightly labeled cells consisted mainly of granulocytes and monocytes, whereas the less-bright cells represented the lymphocyte compartment. Fluorescence microscopy revealed binding on the membrane for both cell populations; the label was, however, rapidly internalized in phagocytes. For both populations binding was saturable, time and temperature dependent, and reversible. Half-saturation occurred at approximately 5 X 10(-7) M (Kd). With respect to lymphocyte subpopulations, no difference of cellular fluorescence was found between unseparated lymphocytes and T cell subsets. In addition, mitogens such as concanavalin A, phytohemagglutinin, phorbol 12-myristate 13-acetate, or OKT3 antibody did not inhibit Dans cyclosporine binding. These results clearly indicate that cyclosporine binds to all peripheral blood lymphocytes, and no preferential binding on T cell subsets can be detected.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367167     DOI: 10.1097/00007890-198403000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical and immunohistochemical investigation.

Authors:  R D Aldridge; H F Sewell; G King; A W Thomson
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 2.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

3.  Effect of cyclosporin A on inflammatory cytokine production by U937 monocyte-like cells.

Authors:  J E Garcia; M R de Cabo; F M Rodríguez; J P Losada; A J López; J L Arellano
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

4.  Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level.

Authors:  J E García; A M López; M R de Cabo; F M Rodríguez; J P Losada; R G Sarmiento; A J López; J L Arellano
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.